Werewolf Therapeutics, Inc. (HOWL)
NASDAQ: HOWL · Real-Time Price · USD
0.4096
+0.0236 (6.11%)
Aug 14, 2026, 2:23 PM EDT - Market open
Werewolf Therapeutics Employees
Werewolf Therapeutics had 14 employees as of March 31, 2026. The number of employees decreased by 25 or -64.10% since the number was last reported on December 31, 2025.
Employees
14
Change
-25
Growth
-64.10%
Revenue / Employee
$1,500,000
Profits / Employee
-$2,472,357
Market Cap
19.91M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2026 | 14 | -25 | -64.10% |
| Dec 31, 2025 | 39 | -7 | -15.22% |
| Dec 31, 2024 | 46 | -1 | -2.13% |
| Dec 31, 2023 | 47 | 1 | 2.17% |
| Dec 31, 2022 | 46 | 7 | 17.95% |
| Dec 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Pluri | 142 |
| Celularity | 115 |
| Citius Pharmaceuticals | 23 |
| Atossa Therapeutics | 16 |
| NewcelX | 12 |
| Neuphoria Therapeutics | 8 |
| Tempest Therapeutics | 5 |
| Marker Therapeutics | 5 |
HOWL News
- 14 days ago - Werewolf Therapeutics Reports Second Quarter 2026 Financial Results and Recent Corporate Updates - GlobeNewsWire
- 14 days ago - Werewolf Therapeutics Quarterly report: Q2 2026 - Filings
- 14 days ago - Werewolf Therapeutics Earnings release: Q2 2026 - Filings
- 3 months ago - Werewolf Therapeutics Reports First Quarter 2026 Financial Results and Recent Corporate Updates - GlobeNewsWire
- 3 months ago - Werewolf Therapeutics Quarterly report: Q1 2026 - Filings
- 3 months ago - Werewolf Therapeutics Earnings release: Q1 2026 - Filings
- 5 months ago - Werewolf Therapeutics hires Piper Sandler to assist in strategic evaluation - TheFly
- 5 months ago - Werewolf Therapeutics reports Q4 EPS (20c), consensus (35c) - TheFly